Abstract
The Lung Allocation Score prioritizes lung transplantation candidates balancing waitlist-mortality and post-transplant survival. The score groups sarcoidosis candidates based on mean pulmonary artery pressure: ≤30 mmHg (Sarcoidosis A) are grouped with COPD and >30 mmHg (Sarcoidosis D) with idiopathic pulmonary fibrosis. We hypothesize that sarcoidosis candidates have a higher waitlist-mortality than other candidates within their LAS grouping. This is a retrospective cohort study of consecutive lung transplantation candidates from the Scientific Registry of Transplant Recipients database from May 2005 to May 2019. We included candidates ≥18 y/o diagnosed with sarcoidosis, COPD or IPF. Univariate, multivariate and survival estimate analysis were performed. We identified 385 sarcoidosis A, 642 sarcoidosis D, 7081 COPD, 10 639 IPF lung transplantation candidates. 17.3% of sarcoidosis D, 14.8% of IPF, 14.3% of sarcoidosis A, and 9.8% of COPD candidates died awaiting transplant. Sarcoidosis A was an independent risk factor for waitlist-mortality. Sarcoidosis A had a lower waitlist survival probability compared to COPD. Sarcoidosis D had the highest waitlist-mortality. IPF candidates had lower waitlist survival probability than sarcoidosis D in the first 60 days after listing. Based on our results the grouping of candidates with sarcoidosis in the allocation systems should be revised to mitigate the waitlist-mortality disparity.
Footnotes
This manuscript has recently been accepted for publication in the ERJ Open Research. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJOR online. Please open or download the PDF to view this article.
Conflicts of interest: The authors of this manuscript have no conflicts of interest to disclose.
This is a PDF-only article. Please click on the PDF link above to read it.
- Received December 22, 2022.
- Accepted May 13, 2023.
- Copyright ©The authors 2023
This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions{at}ersnet.org